Quantessence Capital’s Medpace MEDP Stock Holding History

Quantessence Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,143	Closed	-$359K	–	259
2025 Q2	$359K	Buy	+1,143	New	+$343K	0.11%	132

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantessence Capital's MEDP Position: Q3 2025 in Review

Quantessence Capital sold out of Medpace (MEDP) in Q3 2025, closing a stake of 1,143 shares — an estimated $359K sold.

Quantessence Capital first reported a position in MEDP in Q2 2025 and held it in 1 quarter. The position peaked at $359K in Q2 2025. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

Quantessence Capital reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
Quantessence Capital sold 1,143 Medpace shares in Q3 2025, an estimated $359K.
Quantessence Capital first reported a position in Medpace in Q2 2025 and held it in 1 quarter.
Quantessence Capital's Medpace position peaked at $359K in Q2 2025.
672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Quantessence Capital's 13F filing for Q3 2025, filed 14 Nov 2025.